当前位置:首页 - 行情中心 - 悦康药业(688658) - 财务分析 - 现金流量表

悦康药业

(688658)

  

流通市值:33.82亿  总市值:74.39亿
流通股本:2.05亿   总股本:4.50亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,075,653,051.424,730,583,906.343,615,043,169.942,547,436,817.08
收到的税费返还6,037.3334,924,383.3816,668,881.3216,456,148.48
收到其他与经营活动有关的现金24,236,537.92110,819,768.9247,527,124.7533,979,073.82
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,099,895,626.674,876,328,058.643,679,239,176.012,597,872,039.38
购买商品、接受劳务支付的现金315,666,537.631,450,056,196.211,024,551,353.72638,477,042.15
支付给职工以及为职工支付的现金121,316,932.59447,643,265.18347,415,357.69238,302,774.24
支付的各项税费94,872,705.47393,051,490.49275,937,383.44187,600,196.2
支付其他与经营活动有关的现金421,908,553.711,800,085,524.221,535,440,854.61,046,261,593.28
经营活动现金流出的平衡项目0000
经营活动现金流出小计953,764,729.44,090,836,476.13,183,344,949.452,110,641,605.87
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额146,130,897.27785,491,582.54495,894,226.56487,230,433.51
二、投资活动产生的现金流量:
处置固定资产、无形资产和其他长期资产收回的现金净额124,802.052,474,166.841,895,219.951,655,409.95
处置子公司及其他营业单位收到的现金净额-8,456,769.38,456,769.35,068,845.3
投资活动现金流入的平衡项目0000
投资活动现金流入小计124,802.0510,930,936.1410,351,989.256,724,255.25
购建固定资产、无形资产和其他长期资产支付的现金90,961,646.48497,477,682.58412,381,073256,609,438.02
投资支付的现金-15,500,00015,500,00015,500,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计90,961,646.48512,977,682.58427,881,073272,109,438.02
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-90,836,844.43-502,046,746.44-417,529,083.75-265,385,182.77
三、筹资活动产生的现金流量:
取得借款收到的现金281,730,725387,292,022196,555,00052,000,000
收到其他与筹资活动有关的现金--150,000,000150,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计281,730,725387,292,022346,555,000202,000,000
偿还债务支付的现金63,000,000247,600,000160,000,00050,791,698.63
分配股利、利润或偿付利息支付的现金4,437,371.06505,117,864.3503,779,455.94501,129,116.65
支付其他与筹资活动有关的现金25,026,784.4866,766,205.3824,041,152.487,078,244.87
筹资活动现金流出平衡项目0000
筹资活动现金流出小计92,464,155.54819,484,069.68687,820,608.42558,999,060.15
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额189,266,569.46-432,192,047.68-341,265,608.42-356,999,060.15
四、汇率变动对现金及现金等价物的影响120,751.253,935,520.173,871,677.523,559,659.29
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额244,681,373.55-144,811,691.41-259,028,788.09-131,594,150.12
加:期初现金及现金等价物余额1,373,533,190.291,518,344,881.71,518,344,881.71,518,344,881.7
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,618,214,563.841,373,533,190.291,259,316,093.611,386,750,731.58
补充资料:
净利润-187,494,090.53-208,633,261
资产减值准备-62,405,526.2-18,696,649.06
固定资产和投资性房地产折旧-146,494,090.92-67,481,316.46
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-146,494,090.92-67,481,316.46
无形资产摊销-21,639,039.85-10,563,046.21
长期待摊费用摊销-2,183,943.56-464,577.1
处置固定资产、无形资产和其他长期资产的损失--1,043,142.4--1,143,563.8
固定资产报废损失-3,491,871.15-2,797,089.98
公允价值变动损失-686,875.22--
财务费用-9,276,022.83-2,117,154.15
投资损失--606,257.43-160,883.97
递延所得税--2,576,326.86-1,847,937.06
其中:递延所得税资产减少--2,576,326.86-1,847,937.06
存货的减少--30,606,325.52--44,348,442.4
经营性应收项目的减少-278,300,679.64-209,575,084.71
经营性应付项目的增加-148,970,116.66-50,756,105.38
其他--37,211,737.8--37,211,737.8
现金的期末余额-1,373,533,190.29-1,386,750,731.58
减:现金的期初余额-1,518,344,881.7-1,518,344,881.7
公告日期2024-04-302024-04-302023-10-312023-08-18
审计意见(境内)标准无保留意见
TOP↑